203 related articles for article (PubMed ID: 33595218)
21. Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.
Austin N; Darlow BA; McGuire W
Cochrane Database Syst Rev; 2009 Oct; (4):CD003478. PubMed ID: 19821309
[TBL] [Abstract][Full Text] [Related]
22. Fluconazole prophylaxis against fungal colonization and infection in preterm infants.
Kaufman D; Boyle R; Hazen KC; Patrie JT; Robinson M; Donowitz LG
N Engl J Med; 2001 Dec; 345(23):1660-6. PubMed ID: 11759644
[TBL] [Abstract][Full Text] [Related]
23. Fluconazole to prevent systemic fungal infections in infants: reviewing the evidence.
Wilkerson J; McPherson C; Donze A
Neonatal Netw; 2010; 29(5):323-33. PubMed ID: 20829180
[TBL] [Abstract][Full Text] [Related]
24. Antifungal Susceptibility and Clinical Outcome in Neonatal Candidiasis.
Autmizguine J; Tan S; Cohen-Wolkowiez M; Cotten CM; Wiederhold N; Goldberg RN; Adams-Chapman I; Stoll BJ; Smith PB; Benjamin DK;
Pediatr Infect Dis J; 2018 Sep; 37(9):923-929. PubMed ID: 29369937
[TBL] [Abstract][Full Text] [Related]
25. Prophylactic oral antifungal agents to prevent systemic candida infection in preterm infants.
Austin NC; Darlow B
Cochrane Database Syst Rev; 2004; (1):CD003478. PubMed ID: 14974017
[TBL] [Abstract][Full Text] [Related]
26. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.
Cleminson J; Austin N; McGuire W
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD003850. PubMed ID: 26497056
[TBL] [Abstract][Full Text] [Related]
27. Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis.
Aghai ZH; Mudduluru M; Nakhla TA; Amendolia B; Longo D; Kemble N; Kaki S; Sutsko R; Saslow JG; Stahl GE
J Perinatol; 2006 Sep; 26(9):550-5. PubMed ID: 16940972
[TBL] [Abstract][Full Text] [Related]
28. Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infants.
Autmizguine J; Smith PB; Prather K; Bendel C; Natarajan G; Bidegain M; Kaufman DA; Burchfield DJ; Ross AS; Pandit P; Schell WA; Gao J; Benjamin DK;
J Antimicrob Chemother; 2018 Dec; 73(12):3482-3487. PubMed ID: 30247579
[TBL] [Abstract][Full Text] [Related]
29. Fluconazole prophylaxis for prevention of invasive candidiasis in infants.
Ericson JE; Benjamin DK
Curr Opin Pediatr; 2014 Apr; 26(2):151-6. PubMed ID: 24626156
[TBL] [Abstract][Full Text] [Related]
30. Time to initiation of antifungal therapy for neonatal candidiasis.
Le J; Tran TT; Bui I; Wang MK; Vo A; Adler-Shohet FC
Antimicrob Agents Chemother; 2013 Jun; 57(6):2550-5. PubMed ID: 23507285
[TBL] [Abstract][Full Text] [Related]
31. Prophylactic regimens with fluconazole for candidiasis in neonates under 1.500g: A retrospective chart review of two cohorts.
Silva-Rios J; Camargos P; Correa L; Romanelli R
J Neonatal Perinatal Med; 2019; 12(1):29-36. PubMed ID: 30958318
[TBL] [Abstract][Full Text] [Related]
32. Antifungal prophylaxis for very low birthweight infants: UK national survey.
Clerihew L; McGuire W
Arch Dis Child Fetal Neonatal Ed; 2008 May; 93(3):F238-9. PubMed ID: 17768153
[TBL] [Abstract][Full Text] [Related]
33. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates.
Manzoni P; Stolfi I; Pugni L; Decembrino L; Magnani C; Vetrano G; Tridapalli E; Corona G; Giovannozzi C; Farina D; Arisio R; Merletti F; Maule M; Mosca F; Pedicino R; Stronati M; Mostert M; Gomirato G; ;
N Engl J Med; 2007 Jun; 356(24):2483-95. PubMed ID: 17568029
[TBL] [Abstract][Full Text] [Related]
34. Prophylactic fluconazole in very low birth weight infants admitted to neonatal intensive care unit: randomized controlled trial.
Kirpal H; Gathwala G; Chaudhary U; Sharma D
J Matern Fetal Neonatal Med; 2016; 29(4):624-8. PubMed ID: 25708488
[TBL] [Abstract][Full Text] [Related]
35. Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.
Austin N; Cleminson J; Darlow BA; McGuire W
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD003478. PubMed ID: 26497202
[TBL] [Abstract][Full Text] [Related]
36. Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.
Austin N; Darlow BA; McGuire W
Cochrane Database Syst Rev; 2013 Mar; (3):CD003478. PubMed ID: 23543519
[TBL] [Abstract][Full Text] [Related]
37. Prophylactic fluconazole protocol in very low birth weight infants: invasive candidiasis prevention in a Latin American neonatal intensive care unit.
Valenzuela-Stutman D; Romero AM; Astudillo P
J Perinatol; 2023 Sep; 43(9):1139-1144. PubMed ID: 37253780
[TBL] [Abstract][Full Text] [Related]
38. Neonatal Antifungal Consumption Is Dominated by Prophylactic Use; Outcomes From The Pediatric Antifungal Stewardship: Optimizing Antifungal Prescription Study.
Ferreras-Antolín L; Irwin A; Atra A; Dermirjian A; Drysdale SB; Emonts M; McMaster P; Paulus S; Patel S; Kinsey S; Vergnano S; Whittaker E; Warris A
Pediatr Infect Dis J; 2019 Dec; 38(12):1219-1223. PubMed ID: 31568253
[TBL] [Abstract][Full Text] [Related]
39. Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight.
Kaufman D; Boyle R; Hazen KC; Patrie JT; Robinson M; Grossman LB
J Pediatr; 2005 Aug; 147(2):172-9. PubMed ID: 16126045
[TBL] [Abstract][Full Text] [Related]
40. Fluconazole prophylaxis against fungal colonization and invasive fungal infection in very low birth weight infants.
Parikh TB; Nanavati RN; Patankar CV; Rao S; Bisure K; Udani RH; Mehta P
Indian Pediatr; 2007 Nov; 44(11):830-7. PubMed ID: 18057479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
